ArticleBiomedical optics express2026
Label-free subcellular imaging with dynamic spectrally encoded confocal microscopy (D-SECM) with subpixel jitter correction.
Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present dynamic spectrally encoded confocal microscopy (D-SECM), a high-speed, label-free imaging modality for real-time visualization of subcellular metabolic activity. Sequential, optically sectioned SECM images, with a lateral resolution of 0.62 µm-0.88 µm, were acquired at 100 fps by a modified swept source SECM system, stabilized by fiber-Bragg grating swept source synchronization. D-SECM images are created through real-time pixelwise power spectra mapping into frequency-dependent RGB channels, enabled by GPU-accelerated parallel processing. Validation on freshly excised mouse liver tissue demonstrates that metabolic contrast is detectable with exposure durations as short as 40 ms in the liver. Moreover, volume-prioritized scanning enables three-dimensional D-SECM images to be acquired within a second. In addition to the liver, D-SECM has also been demonstrated in multiple organs, including the lung, thyroid, kidney, and pancreas. These capabilities position D-SECM as a powerful and scalable platform for high-speed, label-free imaging of metabolic dynamics, with unique potential for both basic research and real-time clinical applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.